TrialPath

Find a study

Match me to a study

69 studies

Recruiting now, in plain language. Every study is watched over by an independent ethics board.

ListMap
Weight & metabolicMental healthLungs & breathingHeart & circulationKidneyBrain & memoryBlood disordersImmune & autoimmuneSkin

67 studies on the map

Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study — Northern Arizona Healthcare, FlagstaffA Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine — Rehabilitation & Neurological Services /ID# 248517, HuntsvilleEfficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects — The Belinga Clinic, Fort SmithA Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine — TrialSphere Corp, Merz Investigational Site #0010513, ChandlerA Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine — Mayo Clinic Hospital, PhoenixA Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine — TrialSphere Corp, Merz Investigational Site #0010513, ChandlerA Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years — Rehabilitation and Neurological Services /ID# 270782, HuntsvilleA Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine — Yale-New Haven Children's Hospital - PIN, New HavenA Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine — Xenoscience Inc, PhoenixStudy of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine — Central Research Associates /ID# 260161, BirminghamResponding With Evidence and Access for Childhood Headaches — University of Alabama at Birmingham Children's of Alabama, BirminghamA Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine — Yale University School of Medicine, New HavenA Study of Eptinezumab in Pediatric Participants With Episodic Migraine — Ki Health Partners LLC DBA New England Institute for Clinical Research, StamfordQudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old — Upsher-Smith Clinical Trial Site #5, BirminghamA Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine — Central Research Associates, LLC (CRA) dba Flourish Research, BirminghamA Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults — Central Research Associates, BirminghamA Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine — Flourish - Birmingham, BirminghamStudy of EVO756 in Adults With Migraine — CA Medical Clinic for Headache, Los AngelesA Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine — Arkansas Children's Hospital, Little RockLong-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine — Perseverance Research Center, LLC, ScottsdaleStudy to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17) — Rehabilitation & Neurological Services /ID# 229969, HuntsvilleRandomized Study in Children and Adolescents With Migraine: Acute Treatment — Achieve Clinical Research, LLC d/b/a Accel Research Sites-Neurology and Neurodiagnostic of Alabama, BirminghamMMA Embolization for Refractory Chronic Migraine — Barrow Neurological Institute at St. Joseph's Hospital, PhoenixA Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine — Hope Clinical Research, Canoga ParkStudy Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients — Sunwise Clinical Research, Llc, Walnut CreekBE WELL With Migraine: Brain Education and WELLness With Migraine — Cambridge Health Alliance - Center for Mindfulness and Compassion, CambridgeStudy to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacks — Neurology and Pain Specialty Center /ID# 278508, Aliso ViejoMind Body Balance for Pediatric Migraine — University of Colorado/Children's Hospital Colorado, AuroraReal-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine — University of Miami, Miller School of Medicine, MiamiObservational Study to Assess Adverse Events When Adult Female Participants Are Treated With Ubrelvy (Ubrogepant) or Qulipta (Atogepant) During Pregnancy — Iqvia /Id# 266904, DurhamMind Body Intervention for Chronic Migraine Headaches — Beth Israel Deaconess Medical Center, BostonNIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar Disorder — National Institutes of Health Clinical Center, BethesdaUnhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research — Brain Inflammation Collaborative, DelafieldExternal Trigeminal Nerve Stimulation for Migraine Treatment in Pregnancy — https://public.smart-trial.co/#/public/649d77f0e8f8d0fb993d0c61/6626f6a04f0a3c7dd0860e14/662726d84f0a3c7dd08aeaa0/signup?lang=en-us&enforceLanguage=true, DarienMechanistic Studies of Psilocybin in Headache Disorders — VA Connecticut Healthcare System, West HavenLight Exposure, Migraine Outcomes, and Sleep Quality — ASU DeSmart Lab, TempeStimulation of External Carotid Artery Circulation — University of Texas Medical Branch, GalvestonEfficacy of Nerve Blocks for Episodic Migraine — Mayo Clinic in Rochester, RochesterEfficacy of Xeomin for Migraines in Patients With Traumatic Brain Injuries vs. Anomalous Health Incidents — National Intrepid Center of Excellence (NICOE), BethesdaMigraine in Adolescents — Washington University School of Medicine, St LouisRimegepant as Preemptive Treatment for Predictable Trigger-Induced Migraine in Adult Patients in the US — MedStar Health: Neurology at McLean, McLeanAssessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA — Brown University, ProvidenceOverlapping Pain Trajectory Study — Cincinnati Children's Hospital, CincinnatiAcceptance and Commitment Therapy to Improve Disability in Chronic Migraine — Brigham and Women's / Faulkner Hospital, BostonEndometriosis and Migraine — Washington University School of Medicine, St LouisDoes Nerve Block + Oral Dexamethasone Reduce Recurrence of Headache Within 72 Hrs? — University Medical Center of El Paso, El PasoSupraspinal Processing of Sensory Aspects of Pain — Cincinnati Children's Hospital, CincinnatiEffectiveness of Magnesium in Addition to Prochlorperazine for the Treatment of Migraines — Advocate Christ Medical Center Emergency Department, Oak LawnA Feasibility Trial of Virtual Reality Neurofeedback for Adolescents With Migraine — Children's Mercy, Kansas CityBilateral Middle Meningeal Artery Lidocaine Infusion for Chronic Debilitating Migraines — Neuroscience Institute at Great Neck, Great NeckInvestigation and Modulation of the Central Mu-Opioid Mechanism in Migraine (in Vivo) — University of Michigan, Ann ArborDetermining the Utility of a Behavioral Intervention in Chronic Migraine — Mayo Clinic, PhoenixA Comprehensive Digital Care Program for Migraine Management — Hinge Health, Inc., San FranciscoBOTOX® vs. XEOMIN® for Chronic Migraine — Naval Medical Center Camp Lejeune, JacksonvilleEmgality for Migraine in Breastmilk — University of California, San Francisco, San FranciscoInvestigating Brain Function in People With and Without Visual Snow Syndrome Using Adaptation to Visual Stimuli — University of Minnesota, MinneapolisCocoa Extract for Migraine Trial — Brigham and Women's Hospital, BostonObjectively Diagnose and Monitor Treatment of Light Sensitivity — University of Iowa Health Care, Iowa CityAimovig Pregnancy Exposure Registry — IQVIA Virtual Site, DurhamObservational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant — Evidera, a PPD business unit, WilmingtonAnalysis of Headache Chronification With Imaging, Deep Phenotyping, and Proteomics — Stanford University School of Medicine, StanfordEffectiveness and Tolerability of Zavegepant for Acute Migraine Treatment Among Those Using CGRP Targeting Preventive Medications — Mayo Clinic in Arizona, PhoenixA Comparison of Nurtec ODT to Maxalt MLT-ODT in Adult ED Patients With Migraine Headache — Maimonides Medical Center, BrooklynRELAXaHEAD for Headache Patients (Phase III) — NYU Langone Health, New YorkBilateral Embolization of the Middle Meningeal Arteries for Refractory Chronic Migraine — Johns Hopkins Medicine, BaltimoreClinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial Pain — Peter H Hwang, StanfordChiropractic Care for Episodic Migraine — Osher Center for Integrative Health, Mass General Brigham, Boston